Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mesotherapy With Lidocaine and Ketamine in Complex Regional Pain Syndrome Type 1: A Randomized Double-Blind Trial.

Pain practice : the official journal of World Institute of Pain·2026

Same author

Comparison of the Antithrombotic Strategy Implemented to Prevent Early Recurrence before Closure of Patent Foramen Ovale.

Cerebrovascular diseases (Basel, Switzerland)·2026

Same author

Reasons for encounter in primary care among French patients: Gender differences in presentation rates more pronounced among the patients of male practitioners.

PloS one·2026

Same author

Blood-based biomarkers for Alzheimer's disease in primary care: A French qualitative study exploring perspectives of general practitioners.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026

Same author

Sante publique (Vandoeuvre-les-Nancy, France)·2026

Same author

eCAPRI: a novel tool combining clinical and imaging data for post-TAVI mortality prediction.

European radiology·2025

Search research articles

Related Experiment Videos

[Mini Nutritional Assessment: a reproducibility study for the elderly].

Clément Gonzalez¹, Muriel Rabilloud, Noëlle Bonnetain

¹Département de médecine générale, université Lyon-1, Lyon, France.

Soins. Gerontologie

|November 9, 2012

Summary

This summary is machine-generated.

The Mini Nutritional Assessment (MNA) is a reliable tool for detecting undernutrition in elderly care. While generally effective in nursing homes, standardizing certain assessment items could improve its accuracy.

Related Experiment Videos

Area of Science:

Gerontology
Nutritional Science
Clinical Assessment

Context:

The Mini Nutritional Assessment (MNA) is widely used for nutritional screening in clinical settings.
Validation of the MNA has primarily focused on hospital environments.

Purpose:

To evaluate the reproducibility of the Mini Nutritional Assessment (MNA) in a French nursing home setting for dependent elderly individuals.
To identify areas for improvement in the standardization of MNA items.

Summary:

The study assessed the reliability of the MNA in a specific elderly population within a French nursing home.
Results indicate that the MNA is broadly acceptable for use in this setting.
Specific items within the MNA require further standardization to enhance consistency.

Impact:

Provides evidence on the MNA's utility and limitations in long-term care facilities.
Informs potential revisions to the MNA for improved application in geriatric care.
Highlights the importance of standardized assessment tools in elderly nutrition monitoring.